HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy

被引:157
作者
De Vuyst, Hugo [1 ,2 ]
Lillo, Flavia [3 ]
Broutet, Nathalie [4 ]
Smith, Jennifer S. [5 ]
机构
[1] Int Agcy Res Canc, F-69372 Lyon 08, France
[2] Univ Ghent, Dept Obstet & Gynaecol, Ghent, Belgium
[3] Hosp San Raffaele, IRCCS, AIDS Ctr San Luigi, Virol Lab, Milan, Italy
[4] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland
[5] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA
关键词
cervical neoplasia; highly active antiretroviral therapy; human immunodeficiency virus; human papillomavirus;
D O I
10.1097/CEJ.0b013e3282f75ea1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The objective of this study was to review the literature on the epidemiological association between human papillomavirus (HPV), HIV, and cervical neoplasia, and the impact of highly active antiretroviral therapy (HAART) on this association. MEDLINE was searched using the terms 'human papillomavirus, 'HPV, 'HIV', 'cervix, 'neoplasm', and 'antiretroviral' to identify articles published before December 2006. HIV-infection was strongly associated with a higher prevalence, incidence, and persistence of HPV infection and correlated with prevalence, incidence, persistence, and progression of squamous intraepithelial lesions. The association between HIV and invasive cervical carcinoma has been more difficult to establish, but is now fully recognized. HAART seems to have little, if any, beneficial effect on the natural history of intraepithelial lesions in HIV-positive women. Despite this fact, HAART, does increase the life expectancy of HIV-positive women. Therefore, it remains important to closely monitor HPV-related disease in women with HIV who are receiving HAART, particularly in regions of the world where cervical screening is not available routinely. European Journal of Cancer Prevention 17:545-554 (C) 2008 Wolters Kluwer Health | Lippincott Williams & Wilkins.
引用
收藏
页码:545 / 554
页数:10
相关论文
共 124 条
[1]  
Ahdieh L, 2000, AM J EPIDEMIOL, V151, P1148, DOI 10.1093/oxfordjournals.aje.a010165
[2]   Incidence of malignant neoplasms among HIV-infected persons in Scotland [J].
Allardice, GM ;
Hole, DJ ;
Brewster, DH ;
Boyd, J ;
Goldberg, DJ .
BRITISH JOURNAL OF CANCER, 2003, 89 (03) :505-507
[3]  
[Anonymous], 1992, MMWR Recomm Rep, V41, P1
[4]  
[Anonymous], 1996, MON EV CARC RISKS HU
[5]  
Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823
[6]   Human papillomavirus in a rural community in Zimbabwe: The impact of HIV co-infection on HPV genotype distribution [J].
Baay, MFD ;
Kjetland, EF ;
Ndhlovu, PD ;
Deschoolmeester, V ;
Mduluza, T ;
Gomo, E ;
Friis, H ;
Midzi, N ;
Gwanzura, L ;
Mason, PR ;
Vermorken, JB ;
Gundersen, SG .
JOURNAL OF MEDICAL VIROLOGY, 2004, 73 (03) :481-485
[7]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[8]  
Broker T R, 2001, Dev Biol (Basel), V106, P443
[9]  
Cappiello G, 1997, INT J CANCER, V72, P982, DOI 10.1002/(SICI)1097-0215(19970917)72:6&lt
[10]  
982::AID-IJC11&gt